Wednesday, Oct. 19, 2011
We have no intention of making a profit here. We are committed to achieving the lowest price possible.
- ANDREW WITTY,
- GlaxoSmithKline chief executive, on the cost of a new malaria vaccine that in clinical trials cut the risk of infection by half